Asia-Pacific Contraceptive Drugs and Devices Market | Growth, Trends, and Forecast (2020

ABOUT THIS REPORT
- Market Snapshot
- Market Overview
- Scope of the report
- Key Market Trends
- Competitive Landscape
- Major Players
TABLE OF CONTENTS

Market Snapshot

Study Period:

2017-2025

Base Year:

2019

CAGR:

6.39 %

Major Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

The Asia-Pacific Contraceptive drugs and devices market is anticipated to grow with a CAGR of 6.39%, during the forecast period. The major factors attributing to the growth of the Asia-Pacific contraceptive drugs and devices market include the necessity to avoid unwanted pregnancies and their complications. The need to avoid unwanted pregnancies, especially in the teenage women, is one of the major drivers for this market. It is also observed that more than half of the women identify non-contraceptive health benefits, such as treatment for excessive menstrual bleeding, menstrual pain, and acne, as reasons for use. This is also one of the factors contributing to the growth of the market. The other factors helping the growth of the contraceptives market are the increasing incidence of STDs and the rapid increase in population in the region.

Scope of the report

In basic terms, contraceptives refer to a set of devices, methods, medications, techniques that are used to control births. The use of contraceptive pills, hormonal IUD, copper IUD, condoms, diaphragm, injections, and cervical cap are some commonly used contraceptive methods.

By Products

By Drugs
	Oral Contraceptives
	Topical Contraceptives
	Contraceptive Injectable

By Device
	Condoms
	Diaphragms
	Cervical Caps
	Sponges
	Vaginal Rings
	IUD
	Other Devices

By Gender
		Male
		Female

Geography

Asia-Pacific
	China
	Japan
	India
	Australia
	South korea
	Rest of Asia-Pacific

Report scope can be customized per your requirements. Click here.

Key Market Trends

Oral Contraceptive Segment is Expected to Hold the Largest Market Share in the Asia-Pacific Contraceptive Market

Oral contraceptive pills are seen as the easiest method of contraception in the industry. They act by prohibiting implantation within the uterus if taken within 2-3 days of having unsafe sexual contact. The simplicity of their usage makes them an ideal contraceptive in the market. These are easily marketed across the region by companies and thus easily consumed by a large section of the population, regionally. These factors are expected to contribute to the growth of the market during the forecast period.

To understand key trends, Download Sample Report

Competitive Landscape

The Asia-Pacific contraceptive market is competitive and consists of several players. In terms of market share, few of the major players are currently dominating the market. And some prominent players are vigorously making acquisitions and joint ventures with the other companies to consolidate their market positions across the region. Some of the companies which are currently dominating the market are Bayer AG, Pfizer Inc., Merck & Co., Inc., CooperSurgical Inc., and Allergan PLC.

Major Players

1. INTRODUCTION
1. 1.1 Study Deliverables
2. 1.2 Study Assumptions
3. 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
1. 4.1 Market Overview
2. 4.2 Market Drivers
  1. 4.2.1 Increasing Incidence of the STDs
  2. 4.2.2 Increasing Rate of Unintended Pregnancies
  3. 4.2.3 Rise in Government Initiatives
3. 4.3 Market Restraints
  1. 4.3.1 High Cost of Devices and Treatment
  2. 4.3.2 Side Effects Associated with the Use of Contraceptive Drugs and Devices
4. 4.4 Porter's Five Forces Analysis
  1. 4.4.1 Threat of New Entrants
  2. 4.4.2 Bargaining Power of Buyers/Consumers
  3. 4.4.3 Bargaining Power of Suppliers
  4. 4.4.4 Threat of Substitute Products
  5. 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
1. 5.1 By Products
  1. 5.1.1 By Drugs
    1. 5.1.1.1 Oral Contraceptives
    2. 5.1.1.2 Topical Contraceptives
    3. 5.1.1.3 Contraceptive Injectable
  2. 5.1.2 By Device
    1. 5.1.2.1 Condoms
    2. 5.1.2.2 Diaphragms
    3. 5.1.2.3 Cervical Caps
    4. 5.1.2.4 Sponges
    5. 5.1.2.5 Vaginal Rings
    6. 5.1.2.6 IUD
    7. 5.1.2.7 Other Devices
2. 5.2 By Gender
  1. 5.2.1 Male
  2. 5.2.2 Female
3. 5.3 Geography
  1. 5.3.1 Asia-Pacific
    1. 5.3.1.1 China
    2. 5.3.1.2 Japan
    3. 5.3.1.3 India
    4. 5.3.1.4 Australia
    5. 5.3.1.5 South korea
    6. 5.3.1.6 Rest of Asia-Pacific
6. COMPETITIVE LANDSCAPE
1. 6.1 Company Profiles
  1. 6.1.1 Bayer AG
  2. 6.1.2 Pfizer Inc.
  3. 6.1.3 Merck & Co. Inc.
  4. 6.1.4 CooperSurgical, Inc.
  5. 6.1.5 Allergan PLC
  6. 6.1.6 Johnson & Johnson, Ltd
  7. 6.1.7 Lupin Pharmaceuticals, Ltd
  8. 6.1.8 Mylan Laboratories
  9. 6.1.9 Church & Dwight, Co. Inc
  10. 6.1.10 The Female Health Company
7. MARKET OPPORTUNITIES AND FUTURE TRENDS

** Subject to Availability

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments